Firstly, our study primarily focuses on the role of the COX-2/PGE2/IL-22 axis in neuroinflammatory response in depression, while investigating other possible inflammatory regulatory pathways is not comprehensive enough. Here, IL22 is linked to depressive symptom measurement.